- Rockwell Medical ( NASDAQ: RMTI ) signed a three-year product purchase agreement with Concerto Renal Services, a dialysis provider in skilled nursing facilities.
- Under the agreement, Rockwell will be the primary supplier of liquid and dry acid and bicarbonate concentrates to Concerto including supply and purchasing minimums.
- Rockwell said Concerto operates in 11 states — Illinois, Maryland, Kansas, Missouri, Indiana, Michigan, Ohio, Wisconsin, Georgia, Pennsylvania, and Delaware — and is launching operations in several additional states.
- RMTI +4.65% to $2.25 premarket Feb. 13
For further details see:
Rockwell stock rises on product supply contract with Concerto Renal